DO NOT
use faceLITE™ and decoLITE™ LED system to treat any other conditions apart from those listed in the indications for use. The faceLITE and decoLITE LED systems have not been tested for any other conditions than those listed and the risk is unknown.
DO NOT
use faceLITE™ and decoLITE™ LED system if you are pregnant, planning on becoming pregnant or breastfeeding. The faceLITE and decoLITE LED system has NOT been tested on pregnant or breast-feeding women and therefore the risk to the foetus, neonate or pregnant women is unknown.
DO NOT
use faceLITE™ and decoLITE™ LED system if you have lupus erythematosus, photosensitive eczema or albinism. You may cause a severe skin reaction.
DO NOT
use faceLITE™ and decoLITE™ LED system if you suffer from any photosensitive disorder (sensitization to light). You may cause a severe skin reaction.
DO NOT
use faceLITE™ and decoLITE™ LED system if you are taking any medication that can cause photosensitivity. You may cause a severe skin reaction.
DO NOT
use faceLITE™ and decoLITE™ LED mask if you suffer from light-induced headaches.
DO NOT
use faceLITE™ and decoLITE™ LED mask if you suffer from any genetic conditions of the eye.
Photosensitivity Is A Common Side Effect Of Various Medications.
These can include certain antibiotics, chemotherapy drugs, and diuretics. If you are unsure about any medication you may be taking consult your healthcare provider.
Other Substances Not Listed Above Can Also Cause Photosensitivity.
Common examples of these substances are:
St John's wort, coal tar, deodorants, antibacterial soaps, artificial sweeteners, naphthalene (mothballs), petroleum products, brightening agents found in laundry detergent, and cadmium sulphide (a chemical injected into the skin during tattooing).
There are some instances in which the faceLITE™ / décoLITE™ photofacial may prove unsuitable for an individual. Certain medical conditions or drugs may mean that an individual is unsuitable for the treatment.
Precautions due to drug induced photosensitivity
If you are taking any of the drugs listed below, please read the comments section of the table carefully.
| Product Type | Specific Group or Common Name | Comments |
|---|---|---|
| Anti-Arthritic | Gold 50 or Ridaura | If YES, the treatment cannot be administered |
| Anti- Arthritic or Immunosuppressant | Azathioprine (Imuran, Azasan) | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Anti Arrythmic | Amiodarone (Cordarone, Pacerone), Aratac | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Quinidine | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. | |
| Antibiotics |
Fluoroquinolones: Ciprofloxacin (Cipro), Levofloxacin (Levaquin),
Lomefloxacin (Maxaquin),Norfloxacin (Noroxin), Ofloxacin (Floxin) Tetracyclines: Demeclocycline (Declomycin), Doxycycline (Vibramycin), Minocycline (Minocin), Oxytetracycline (Terramycin) Others: Azithromycin (Zithromax), Capreomycin (Capastat), Ceftazidime (Fortaz),cycloserine (Seromycin),Metronidazole (Flagyl), nalidixic acid (NegGram), pyrazinamide, sulfamethoxazole/ trimethoprim (Bactrim) |
If YES, the medication has not been taken within the last 5 days. |
| Anti-Cancer | Bexarotene (Targretin), Capecitabine (Xeloda), Dacarbazine (DTIC), Epirubicin (Ellence), Fluorouracil (5-FU), Interferon alfa (Intron A, Alferon-N), Methotrexate (Mexate), Pentostatin (Nipent), Procarbazine (Matulane), Tretinoin, oral (Vesanoid), Vinblastine (Velban, Velbe) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 1 /100 and 5/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Anticonvulsants | Carbamazepine (Tegretol), Felbamate (Felbatol), Gabapentin (Neurontin), Lamotrigine (Lamictal), Oxcarbazepine (Trileptal), Topiramate (Topamax), Valproic acid (Depakene) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Antifungals | Flucytosine (Ancobon), Griseofulvin (Fulvicin, Gris-PEG), Terconazole (Terazol) Voriconazole (VFEND) | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Antihistamines | Cetirizine (Zyrtec), Diphenhydramine (Benadryl), Loratadine (Claritin), Promethazine (Phenergan) | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Antihypertensives | Captopril (Capoten), Diltiazem (Cardizem, Tiazac), Enalapril (Vasotec), Nifedipine (Procardia), Sotalol (Betapace) | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Antimalarial | Chloroquine (Aralen), Hydroxychloroquine (Plaquenil), Pyrimethamine (Daraprim), Pyrimethamine/sulfadoxine (Fansidar), Quinine | If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Antipsychotics | Phenothiazines: Chlorpromazine (Thorazine), Fluphenazine (Prolixin), Perphenazine (Trilafon), Prochlorperazine (Compazine), Thioridazine (Mellaril), Trifluoperazine (Stelazine) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 2/100 and 3/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Antiretroviral | Ritonavir (Norvir), Saquinavir (Fortovase,Invirase), Zalcitabine (Hivid) | If YES, it is at the discretion of the client as to whether they commence the treatment. If YES, it is at the discretion of the client as to whether they commence the treatment. There is approximately a 2/100 chance of a light reaction. |
| Antiviral | Amantadine (Symmetrel), Acyclovir (Zovirax) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is approximately a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Cardiovascular | Thiazide
diuretics: Bendroflumethiazide (Corzide), Chlorthalidone (Thalitone),
Hydrochlorothiazide (Microzide), Hydroflumethiazide (Diucardin), Indapamide (Lozol),
Methyclothiazide (Enduron), Metolazone (Zaroxolyn), Polythiazide (Renese)
Diuretics, Other: Furosemide (Lasix), Triamterene (Dyrenium) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
| Lipid regulators Other | Fenofibrate (Tricor) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Non-steroidal anti-inflammatory (NSAIDs) Analgesics | Diclofenac (Voltaren, Cataflam), Naproxen (Anaprox) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a <1 /100 chance of a light reaction. If the client has stopped taking the medication for ≥ 1 day, then the treatment can be administered. |
| Sedatives | Alprazolam (Xanax), Chlordiazepoxide (Librium), Zaleplon (Sonata), Zolpidem (Ambien) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Skin agents (acne) | Isotretinoin (Accutane, Roaccutane) Tretinoin topical (Renova, Retin-A) Tazarotene (Tazorac) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 5/100 and a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
| Skin agents (hair) | Coal tar, Minoxidil (Rogaine) | If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is <0.5 /100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
THE BENEFITS
Anti-Aging Infra-Red & Red Light Therapy
Reduces Fine Lines & Wrinkles
Boosts collagen for a youthful appearance
Tissue Oxygenation
Light therapy enhances cell oxygenation.
Fades Hyperpigmentation
Reduces dark spots and discoloration
Hydrates & Nourishes
Locks in moisture for long-lasting hydration
Minimize Pores
Refines skin texture for a smoother, clearer look
Boosts Circulation
Enhanced blood flow for a healthy complexion
About faceLITE
faceLITE is a UK-based brand offering clinically proven LED light therapy masks for at-home use. Backed by science and developed by the experts behind some of the world’s most trusted professional devices, our red and near-infrared masks target wrinkles, dullness, redness, and uneven texture. Discover the power of medical-grade skincare — without the clinic visit.
Part of the iSMART Developments family – the original designer, developer, and manufacturer behind some of today's leading LED skincare and beauty companies.
Copyright ©2025 faceLITE
Website by Solved Marketing
- Al seleccionar una opción, se actualiza toda la página.
- Se abre en una nueva ventana.